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 Background: This study was designed to test the hypothesis that antioxidant Vitamin C prevents the impairment of endo-
thelial function during prolonged sitting.
 Material/Methods: Eleven men (24.2±4.4 yrs) participated in 2 randomized 3-h sitting trials. In the sitting without vitamin C (SIT) 
and the sitting with vitamin C (VIT) trial, participants were seated for 3 h without moving their legs. Additionally, 
in the VIT trial, participants ingested 2 vitamin C tablets (1 g and 500 mg) at 30 min and 1 h 30 min, respec-
tively. Superficial femoral artery (SFA) flow-mediated dilation (FMD) was measured hourly for 3 h.
 Results: By a 1-way ANOVA, there was a significant decline in FMD during 3 h of SIT (p<0.001). Simultaneously, there 
was a significant decline in antegrade (p=0.04) and mean (0.037) shear rates. For the SIT and VIT trials by a 
2-way (trial x time) repeated measures ANOVA, there was a significant interaction (p=0.001). Pairwise testing 
revealed significant between-SFA FMD in the SIT and VIT trial at each hour after baseline, showing that VIT 
prevented the decline in FMD 1 h (p=0.009), 2 h (p=0.016), and 3 h (p=0.004). There was no difference in the 
shear rates between SIT and VIT trials (p>0.05).
 Conclusions: Three hours of sitting resulted in impaired SFA FMD. Antioxidant Vitamin C prevented the decline in SFA FMD, 
suggesting that oxidative stress may contribute to the impairment in endothelial function during sitting.
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Background
Increased sitting time has been associated with increased risk 
of cardiovascular disease and mortality [1]. Prolonged sitting 
can create a unique physiological milieu in the lower extrem-
ity vasculature, leading to conditions conducive to the devel-
opment of atherosclerosis [2]. For instance, 5 h of sitting has 
been shown to increase calf blood pooling and decrease thigh 
blood flow [3,4]. Greater than 3 h of sitting has also been 
shown to increase diastolic blood pressure (BP), mean arterial 
pressure (in the arm and leg), and total peripheral resistance 
[4,5]. Furthermore, only 2 h of sitting significantly increased 
whole-blood viscosity in the leg [6]. In the first experiment in-
vestigating the effects of sitting on vascular shear stress and 
endothelial function, Padilla et al. [5] discovered that 3 h of 
sitting significantly attenuated vascular shear in the popliteal 
artery; however, this was not associated with a concomitant 
decline in endothelial function measured by FMD. Contrary to 
this study, we recently discovered that 3 h of sitting results in 
a decline in mean shear rate in the SFA in addition to a signif-
icant decline in endothelial function when all measurements 
are made in the seated position [7]. Interestingly, in the vas-
cular system, areas of low vascular shear stress have been as-
sociated with increased oxidative stress [8] and impaired en-
dothelial function [8]. Additionally, low shear stress may be an 
etiological mechanism for atherosclerosis [9].
The human vasculature is internally coated with a single lay-
er of cells called the endothelium, which becomes functional-
ly impaired in the process of atherosclerosis [10]. Nitric oxide 
(NO), which is a critical molecule involved in maintaining the 
antiatherogenic properties of the endothelium [11], is synthe-
sized from L-arginine by endothelial NO synthase (eNOS) in the 
presence of laminar shear stress and co-factors such as nico-
tinamide adenine dinucleotide phosphate (NADPH) and tetra-
hydrobiopterin (BH4) [12]. Shear stress associated with phys-
ical movement augments NO bioavailability [13] and thereby 
improves endothelial function [12]. Conversely, sitting decreas-
es lower extremity shear rates [5,7], and hence it is possible 
that sitting may reduce NO bioavailability in the lower extrem-
ities. Indeed, low shear stress leads to decreased expression 
of NOS [8]. Our group has recently proposed that prolonged 
sitting may lead to low vascular shear-related impairment in 
endothelial function involving mechanisms related to oxida-
tive stress [2]. We have recently address the first part of this 
hypothesis and shown that prolonged sitting decreases mean 
shear rate and impairs endothelial function in SFA [7].
The purpose of the current study was to determine if antiox-
idant Vitamin C prevents the decline in SFA endothelial func-
tion during prolonged sitting. We hypothesized that there 
would be a significant decline in SFA FMD from baseline dur-
ing 3 h of sitting. Previous studies from our lab and others 
have demonstrated vitamin C to be effective in preventing 
the oxidative stress-mediated decline in endothelial function 
in a variety of physiological stressors, including, but not limit-
ed to, hypertension [14] and increased retrograde shear [15]. 
Therefore, we hypothesized that vitamin C would prevent the 
decline in SFA endothelial function during 3 h of sitting.
Material and Methods
Study design (Figure 1)
This study consisted of 2 screening visits and 2 sitting trials con-
ducted in random sequence, the first with 3 h of uninterrupted 
sitting (SIT) and the second with oral Vitamin C during uninter-
rupted sitting (VIT). FMD was measured at baseline, 1 h, 2 h, and 
3 h in both the trials. All procedures for the study were approved 
by the Indiana University Institutional Review Board, and par-
ticipants gave written informed consent for their participation.
Participants
To be included, participants (all men) had to self-report that 
they were nonsmokers, and not taking any anti-hypertensive, 
lipid lowering, or anti-diabetic medications. Participants need-
ed to have total cholesterol £240 mg·dl–1 and triglycerides £200 
mg·dl–1 and fasting blood glucose <120 mg·dl–1. We recruited 
individuals who performed <150 min/week–1 of moderate-in-
tensity physical activity or <75 min/week–1 of vigorous-intensity 
physical activity [16]. Participants were asked to maintain their 
regular diet patterns throughout the study duration and to dis-
continue any over the counter antioxidant supplement at least 
7 days prior to the first session of testing. Based on our pilot 
data, for the primary dependent variable SFA FMD, we estimated 
that 12 participants would be needed to find a significant dif-
ference between trials with statistical power of >0.80 at a£0.05.
Screening visits
At the first visit, all experimental procedures were explained to 
the participants and they were familiarized with the lab setting. 
SIT
FMD
0 hr 0:30 hr 1:30 hr1 hr 2 hr 3 hr
0 hr 0:30 hr 1:30 hr1 hr 2 hr 3 hr
FMD FMD FMD
FMD FMD FMD FMD
VIT
Figure 1.  Study design. SIT represents prolonged 3 h of sitting. 
VIT represents prolonged sitting with intermittent 
vitamin C. FMD was measured at 0, 1, 2, and 3 h. 
 Represents vitamin C. Participants ingested 1 g 
vitamin C at 30 min and 500 mg at 1 h 30 min.
1016
Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]  
[ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]  
[Chemical Abstracts/CAS] [Index Copernicus]
Thosar S.S. et al.: 
Prolonged sitting and oxidative stress
© Med Sci Monit, 2015; 21: 1015-1021
CLINICAL RESEARCH
This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivs 3.0 Unported License
If the participants volunteered to participate in the study, a writ-
ten informed consent was obtained. Height, weight, and BP (in 
triplicate in a seated posture) were measured using standard 
procedures and a medical health history and habits question-
naire [7] was completed to screen for any preexisting cardio-
vascular or metabolic condition and physical activity levels. BP 
(in triplicate) was measured during an additional screening vis-
it at the same time of day, to confirm previous measurements.
Testing trials
Participants arrived at the laboratory after an overnight fast of 
at least 6 h between 07:00 and 09:00 h. The arrival time was 
matched for both trials within each subject. Participants were 
asked to refrain from any caffeinated drink for at least 8 h pri-
or to reporting to the lab. Upon their arrival in the lab, all par-
ticipants self-reported adhering to this dietary schedule. During 
both trials, the participants remained seated for 3 h without mov-
ing their legs (perpendicular to the floor) and feet (flat on the 
ground). Participants were allowed to move their arms, although 
not vigorously; for example, to use a computer or do light read-
ing during the non-testing periods of the trials. Arm movement 
was not quantified. The FMD and other vascular function pa-
rameters were measured at baseline, 1 h, 2 h, and 3 h. Baseline 
measurements were made after ~20 min of seated rest. The 2 
trials were performed in random order, separated by a minimum 
of 2 and a maximum of 7 days. The SIT trial was uninterrupted 
sitting for 3 h, whereas in the VIT trial participants ingested 2 
Vitamin C tablets (with water); 1 g at 30 min and 500 mg at 1h 
30 min during the sitting interval. Doses were determined based 
on pilot data and were not tailored to body weight.
SFA FMD
SFA endothelial function was measured by FMD in accordance 
with current guidelines [17]. We chose SFA for 2 reasons: (1) It 
is a readily accessible artery to use for measuring FMD in a sit-
ting position; and (2) SFA FMD has been shown to be largely 
NO-dependent [18]. Each measurement was performed in a 
dark, quiet, and climate-controlled room (22–25oC) room. A 5×84 
cm automatic BP cuff (E-20 rapid cuff inflator; D.E. Hokanson, 
Bellevue, WA., USA) was placed on their right thigh about 7 
cm above the knee joint, distal to the SFA recording location. 
Images of the SFA were obtained longitudinally 7–10 cm below 
the inguinal line with a 2-D high-resolution ultrasound system 
(Terason t3000, Teratech Corp., Burlington, MA, USA), using a 
5–12-MHz multifrequency linear-array transducer. Once sat-
isfactory images of near and far arterial walls were obtained, 
the transducer was secured and stabilized in a stereotactic 
clamp, and landmarks were made on the subject’s skin to en-
sure similar placement of the transducer for subsequent FMD 
procedures and shear rate assessments within and between 
trials. Participants were encouraged to maintain the landmarks 
between the 2 trials. In addition to imaging the arterial dimen-
sions, Doppler ultrasound was used to concurrently measure 
SFA blood velocity. Doppler flow signals were corrected at an 
insonation angle of 60°, and the sample volume was placed 
in the middle of the artery.
Diameter images and Doppler measurements of blood velocity 
were continuously recorded for 45 s at baseline prior to cuff in-
flation. The automatic BP cuff was then rapidly inflated to 250 
mmHg and maintained for 5 min until cuff deflation. Diameter 
and blood velocity recordings resumed prior to cuff deflation 
and continued for 5 min after deflation. Ultrasound images 
were continuously recorded at 5 frames/s–1 with Camtasia 
(TechSmith, Okemos, MI, USA), and stored as .avi files [7]. This 
procedure was repeated hourly across the sitting intervals. All 
measurements were made in the seated position.
Arterial diameters and blood velocities
Off-line analysis of diameters were performed using automat-
ed edge-detection software (Brachial Analyzer, Medical Imaging 
Applications LLC, Coralville, IA, USA) as previously described [7]. 
This software allows the technician to determine a region of in-
terest where the near and far vessel walls are most clear. The 
vessel wall borders are then detected using an optimal graph 
search-based segmentation that uses a combination of pixel 
density and image gradient as an objective function. All analyzed 
images were reviewed by the technician and edited when need-
ed to ensure that diameter measures were always determined 
from the intima-lumen interface at the near and far vessel wall. 
Blood velocities were determined using internally validated cus-
tom-made software by selecting a region of interest that sur-
rounded the Doppler wave. The velocity-time integral was used 
to calculate the mean blood velocity. The peak dilation after cuff 
deflation was determined using the highest 3-s moving average 
and FMD was presented as a percentage change from baseline 
diameter (FMD%). SFA shear rate used as an estimate of arte-
rial shear stress and was calculated for each FMD% at baseline 
and during the post-occlusion period using the following formu-
la: Vm·D–1, where V m is mean blood velocity (cm·s–1) and D is 
mean arterial diameter (cm). All measurements and analysis were 
performed by a single researcher (ST) who was blinded to the 
participant identity and treatment condition for each image file.
Statistical analysis
Descriptive analysis was performed to summarize subject char-
acteristics (Table 1). Within both trials, 1-way ANOVA was con-
ducted on the baseline diameter as the dependent variable. 
Within the SIT trial, a 1-way ANOVA was conducted on the de-
pendent variables baseline diameter, FMD%, and shear rates 
(antegrade shear rate, mean shear rate, retrograde shear rate, 
peak shear rate, and shear rate [area under the curve] SRauc 
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(area from deflation up until peak dilation)). When an effect 
was found, pairwise comparisons were used to locate signif-
icant differences across time from baseline. Observed effect 
size was reported for ANOVA interactions as partial eta squared 
(h2). Comparisons across the 2 treatment conditions for FMD 
and shear rates (antegrade shear rate, mean shear rate, ret-
rograde shear rate, peak shear rate, and shear rate [area un-
der the curve] were performed using 2-way repeated measures 
ANOVA, evaluating the effect of sitting on the vasculature dif-
fered between conditions (with and without Vitamin C). We 
were only interested in the differences between SIT and VIT 
at each time-point; hence, pairwise comparisons were used to 
identify significant differences at each time-point if the main 
effects were positive. Alpha level for statistical significance was 
set a priori at 0.05. All statistical calculations were performed 
using IBM SPSS Statistics 22.0 software (IBM SPSS, Inc.).
Results
We recruited and tested 12 healthy, inactive participants (See Table 
1 for subject characteristics). We had an incomplete ultrasound 
image at 1 time point on 1 subject and this subject was omitted 
from all analysis. As a result, data on 11 participants is presented.
Tests to identify the effects of SIT
SFA FMD% (Figure 2)
By one way ANOVA there was a significant decline in FMD% 
from baseline during 3 hr of sitting (p<0.001, h2=0.506). 
Pairwise comparisons indicated the difference to be between 
baseline and 1hr (p=0.003), 2 hr (p=0.014) and 3 hr (p=0.013).
SFA shear rates
There was a significant decline in antegrade shear rate (p=0.04, 
h2=0.238) and mean shear rate from baseline to 3 h (p= 0.037, 
h2=0.506). There were no significant differences in retrograde 
shear rate, peak shear rate, and shear rate area under the curve 
(SRauc) from baseline to 3 h (P>0.05).
Baseline diameters between SIT and VIT:
Using pairwise comparisons, there was a significant difference 
between baseline diameters in the SIT and VIT trial (p=0.019). 
There was, however, no significant difference between the 
baseline diameters at 1 h, 2 h, or 3 h (p>0.05).
Tests to identify differences between SIT and VIT
SFA FMD% between SIT and VIT (Figure 2)
There was a significant trial x time interaction for SFA FMD 
(p=0.001, h2=0.406). The variable of interest was FMD% be-
tween each time-point. We conducted pairwise comparisons 
to investigate the differences between SIT and VIT FMD% at 
each hour. Baseline SFA FMD% did not differ between the 2 
trials (p=0.093). However, FMD% was significantly different be-
tween trials at 1 h (p=0.009), 2 h (p=0.016), and 3 h (p=0.004) 
with VIT preventing the decline of FMD.
Using 2-way repeated measures ANOVA, there was a signifi-
cant time x trial SRauc interaction. Pairwise comparisons in-
dicated a significant difference in SRauc at baseline (p=0.017) 
and at 2 h (p=0.024) between the SIT and VIT trials. It is im-
portant to note that the SRauc analysis was for n=5 because 
Variable Value
N 11
Age (yrs)  24.2±4.4
BMI (kg·m2)  23.6±3.4
Systolic blood pressure (mmHg)  116±10
Diastolic blood pressure (mmHg)  77.3±6
Total cholesterol (mg/dl)  171.5±32.7
LDL cholesterol (mg/dl)  98±29.6
HDL cholesterol (mg/dl)  57.8±13.6
VLDL cholesterol (mg/dl)  15.7±9.8
Triglycerides (mg/dl)  78±49
Glucose (mg/dl)  91±6.5
Table 1. Subject demographics.
Data represented as mean ±SD.
Figure 2.  FMD in the superficial femoral artery during 3 h of 
sitting during the sitting (SIT) and Vitamin C (VIT). 
Error bars represent standard deviations. * Indicates 
significant difference between trials at p£0.05. # 
Indicates significant difference from baseline. Error 
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there were multiple participants who did not have an arterial 
dilation in response to hyperemia. There were no significant 
differences between antegrade (p=0.193), mean (p=0.605), 
peak (p=0.187), or retrograde shear (0.723) rates between SIT 
and VIT trials (p>0.05). Baseline diameters and all flow data 
are presented in Table 2
Discussion
The purpose of this study was to determine if antioxidant vi-
tamin C prevents impairment of SFA endothelial function dur-
ing prolonged sitting. This is the first study to our knowledge 
to experimentally investigate the role of oxidative stress dur-
ing prolonged sitting. We hypothesized that there would be a 
significant decline in SFA FMD from baseline during 3 h of sit-
ting and that antioxidant vitamin C would prevent the decline 
in SFA FMD during 3 h of sitting. Indeed, in support of our hy-
pothesis, we found a significant decline in SFA FMD during 3 
h of sitting (SIT trial), which was counteracted by Vitamin C 
(Figure 2). Our results suggest that endothelial function in the 
SFA is significantly impaired from baseline during a 3-h ses-
sion of uninterrupted sitting, beginning sometime before the 
first hour. We also found that there was an associated decline 
in antegrade and mean shear rates from baseline to 3 h of 
sitting in the SIT trial. Based on the results from the VIT trial, 
the mechanism responsible for the decline in FMD during SIT 
is suggestive of an oxidative stress mechanism. There is only 
1 other study to our knowledge that has directly investigat-
ed oxidative stress as a potential mechanism for endothelial 
dysfunction in a model of physical inactivity. In an animal mod-
el for chronic inactivity, Laufs et al. [19] found that 6 weeks of 
inactivity significantly increased NADPH oxidase, superoxide, 
and reactive oxygen species (ROS), and resulted in endothelial 
dysfunction and increased atherosclerosis in sedentary mice as 
compared to mice who voluntary trained on running wheels. 
It is well known that exercise-induced shear stress facilitates 
beneficial endothelial adaptations [20]; hence, it is tempting 
to speculate that the endothelial dysfunction from oxidative 
stress in Laufs’ [19] study may be a result of low shear stress 
in the sedentary mice as compared to the running mice. It is 
important to note that this study induced chronic inactivity, 
whereas we were looking at acute inactivity, but there is no 
other study to our knowledge which has looked at oxidative 
stress during inactivity. We have recently shown (and data pre-
sented in this paper) that there is a significant decline in mean 
shear rate during 3 h of siting. Low mean shear rate has been 
implicated in reduced NO bioavailability and in decreased ac-
tivity of eNOS [21]. Hence, in the absence of biological mark-
ers (see limitations) to test if the impairment in endothelial 
function is caused by mechanisms related to oxidative stress, 
we used vitamin C in our research design.
Vitamin C and endothelial function
Use of vitamin C is a novel and critical aspect of this proj-
ect because it provides suggestive evidence on the mecha-
nisms for endothelial dysfunction during sitting. Vitamin C is 
an antioxidant and has been previously used in endothelial 
function to counteract oxidative stress (and to discover this 
SIT VIT
0 hr 1 hr 2 hr 3 hr 0 hr 1 hr 2 hr 3 hr
Baseline 
diameters 
6.32±0.66* 6.36±0.74 6.50±0.70 6.33±0.77 6.61±0.55* 6.42±0.76 6.29±0.74 6.38±0.76
Antegrade 7.7±1.36 5.77±2.39^ 5.87±2.17^ 6.48±1.79 7.03±3.5 8.58±6.91 6.56±3.08 6.22±2.39
Mean 5.03±1.58 2.9±2.94^ 3.14±1.23^ 3.69±1.28 5.17±7.54 4.44±4.23 2.99±2.6 3.17±2.14
Retrograde 2.65±1.16 2.87±1.79 2.73±1.55 2.80±1.33 3.31±3.06 3.87±3.39 3.30±1.84 2.83±1.32
Peak 54.21±69.10 21.01±13.50 28.51±13.50 23.10±10.30 24.56±16.28 24.74±16.10 23.30±17.76* 17.78±10.94*
SRauc 
(a.u)
831.9±228.1# 439.5±294.2 359.6±220.7$ 489.7±265.7 247.9±195.9# 488.8±255.3 622.6±291.7$ 351.7±228.7
FMD: 
SRauc 
0.005±0.002 0.24±0.05 0.002±0.002 0.002±0.002 0.05±0.05 0.007±0.007 0.03±0.04 0.18±0.36
Table 2.  Baseline diameters (mm), Shear rates (s–1), SRauc and normalized FMD in the SFA during the SIT and VIT trial at baseline, 1 hr, 
2 hr and 3 hr.
SFA shear rates (s–1) and baseline diameters (mm) during SIT and VIT trials. Data represented as Mean ±SD. * Indicates baseline 
diameters significantly different from each other at 0 hr only. ^ Indicates antegrade and mean shear rates significantly different from 
0hr in SIT trial only. # and $ indicate significant difference between SRauc in the SIT and VIT trial at baseline and at 2 hrs respectively. 
Data for SRauc and FMD: SRauc are from 5 participants. Please see limitations for details.
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mechanism) from smoking [22], high-fat meals [23], exercise 
[24], and increased oscillatory shear [15]. Our results show 
that vitamin C prevents the decline in SFA FMD during 3 h 
of sitting, suggesting a possible role of mechanisms involv-
ing oxidative stress causing the decline of FMD during sitting. 
The dose of vitamin C ingested by our participants was high-
er than the recommended daily allowance and was expected 
to saturate participants’ plasma [25]. There are several po-
tential pathways by which vitamin C may have prevented the 
decline in SFA FMD during sitting. Vitamin C has been shown 
to restore NO activity [14] and decrease the activation of vas-
cular NADPH oxidase (a pro-oxidant) [26]. Vitamin C supple-
mentation has been found to protect BH4 and thus the activi-
ty of eNOS [27,28]. Vitamin C also allows the recycling of BH3 
radicals to a stable BH4 in the presence of ROS [29], thereby 
maintaining NO production [30]. Indeed, vitamin C may have 
directly counteracted oxidative stress by scavenging elevated 
superoxide radicals [31]. Vitamin C, when ingested at 30 min 
and 1 h 30 min, prevented the decline in endothelial function 
during 3 h of sitting. This may suggest that mechanisms in-
volving oxidative stress may be present during prolonged sit-
ting, which are counteracted by vitamin C. Using a placebo in 
addition to vitamin C was also considered. Placebos are used 
in trials to conceal whether a treatment is being given or not 
and hence to control for the psychosomatic effects. It is high-
ly unlikely that the vascular responses including blood flow 
patterns and diameters can be modulated by psychosomatic 
effects in a period of 3 h. Vitamin C also did not change blood 
flow patterns during the trial. Furthermore, use of vitamin C 
was based on pilot data and was meant only to uncover the 
oxidative stress mechanism.
Alternative mechanisms
There are alternative mechanisms which may attenuate en-
dothelial function during prolonged sitting. For example, vis-
cosity has been shown to be higher in the legs after a session 
of 2 h of sitting [6], and in the presence of low mean shear 
rates [32]. Viscosity has been positively associated with in-
creased coagulation and inflammatory markers [33], which in 
turn have been strongly associated with impaired endotheli-
al function [34]. It is possible that vitamin C counteracted the 
viscosity and inflammation in our experiment. Indeed, plasma 
vitamin C has anti-inflammatory effects and is inversely asso-
ciated with viscosity [35]. Additionally, skeletal muscle inac-
tivity results in an increase in intracellular calcium concentra-
tion, which may result in increased NAD(P)H oxidase activity 
elevating superoxide production [36].
Limitations
Our study is novel and the results have public health signif-
icance. However, it is not devoid of limitations. For example, 
not being able to obtain blood samples from the lower extrem-
ities is a clear limitation. Blood samples from the lower ex-
tremities would have increased our understanding about the 
physiological milieu in the legs during sitting and would have 
allowed us to measure viscosity and oxidative stress markers. 
Viscosity measurement would have allowed us to explore al-
ternative mechanisms for FMD attenuation during sitting, and 
calculate shear stress rather than using shear rate as a sur-
rogate measure for shear stress. Oxidative stress measure-
ments from the legs would have conclusively supported the 
oxidative stress mechanism. It has to be understood, howev-
er, that obtaining continuous blood samples from a lower ex-
tremity vein in this design is difficult, and these investigators 
tried this technique in 5 people multiple times before it was 
deemed logistically impossible (technical difficulty in addition 
to subject discomfort) even with the use of a topical anesthet-
ic. We did collect venous blood samples from the antecubital 
vein and analyzed the plasma for oxidative stress biomark-
ers. However, these biomarkers did not change during 3 h of 
sitting as compared to baseline, similar to the brachial artery 
FMD, implying that the local lower extremity effect could not 
be detected using the upper extremity measurements [37]. We 
did not measure BP during SIT. BP is known to increase during 
sitting [4,5] and may lead to endothelial dysfunction. Increased 
BP is also known to impair endothelial function via the oxida-
tive stress mechanism [14]. Some of our participants had no 
FMD at some time-points, which did not allow us to calculate 
SRauc until the point of maximum dilation. Since SRauc is the 
stimulus that causes the dilation, we cannot speculate if it was 
the stimulus that was attenuated. Our study was conducted in 
young and inactive men and more research needs to be done 
to replicate these findings in women and subjects of differ-
ent age groups. Despite these minor limitations, our study is 
the first to our knowledge to discover the mechanism behind 
vascular impairment during prolonged sitting.
Conclusions
Three hours of sitting leads to a significant decline in endo-
thelial function, most likely through an oxidative stress mech-
anism. Sitting is a common activity of modern human beings. 
Repeated sitting sessions may lead to chronically altered shear 
patterns, oxidative stress, endothelial dysfunction, and a pre-
disposition to atherosclerosis. With the prevalence of seden-
tary behavior increasing, vitamin C as a regular supplement 
taken during the seated sessions may play a role in maintain-
ing vascular health in the inactive population.
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